Abstract
Local recurrence rates play an important role in the evaluation and judgement of local treatment modalities in breast cancer. In the medical literature different methods for the calculation of these rates have been used. In this note we discuss the methods, the observed differences, and the interpretation of the resulting estimates.
Similar content being viewed by others
References
Fisher B, Anderson S, Redmond CK, Wolmark N, Wickerham DL, Cronin WM: Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 333: 1456–1461, 1995
Christian MC, McCabe MS, Korn EL, Abrams JE, Kaplan RS, Friedman MA: The National Cancer Institute audit of the National Surgical Adjuvant Breast and Bowel Project protocol B-06, N Engl J Med 333: 1469–1474, 1995
Fisher B, Redmond C, Poisson R, Margolese R, Wolmark N, Wickerham L, Fisher E, Deutsch M, Caplan R, Pilch Y, Glass A, Shibata H, Lerner H, Terz J, Sidorovich L: Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 320: 822–828, 1989
Fisher B, Anderson S, Fisher ER, Redmond C, Wickerham DL, Wolmark N, Mamounas EP, Deutsch M, Margolese R: Significance of ipsilateral tumor recurrence after lumpectomy. Lancet 338: 327–331, 1991
Fisher B, Anderson S: Conservative surgery for the management of invasive and noninvasive carcinoma of the breast: NSABP trials: National Surgical Adjuvant Breast and Bowel Project. World J Surg 18: 63–69, 1994
Korn EL, Dorey FJ: Applications of crude incidence curves. Stat Med 11: 813–829, 1992
Dignam JJ, Weissleld LA, Anderson SJ: Methods for bounding marginal survival distributions. Stat Med 14: 1985–1998, 1995
Harris JR, Morrow M: Local management of invasive breast cancer. In: Harris JR, Lippman ME, Morrow M, Hellman S (eds) Diseases of the Breast, Lippincott-Raven, Philadelphia, 1996, pp 487–547
Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457–481, 1958
Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. Wiley, New York, 1980
Aalen OO, Johansen S: An empirical transition matrix for non-homogencous Markov chains based on censored observations. Scand J Statist 5: 141–150, 1958
Gelman R, Gelber R, Henderson JC, Coleman CN, Harris JR: Improved methodology for analyzing local and distant recurrence. J Clin Oncol 8: 548–555, 1990
Marubini E, Valsecchi MG: Analysing Survival Data from Clinical Trials and Observational Studies. Wiley, Chichester, 1995
The German Breast Cancer Study Group (GBSG): Therapy of small breast cancer — four-year results of a prospective non-randomized study. Breast Cancer Res Treat 34: 1–13, 1995
Arriagada R, Rutqvist LR, Mattsson A, Kramar A, Rotstein S: Adequate locoregional treatment for early breast cancer may prevent secondary dissemination. J Clin Oncol 13: 2869–2878, 1995
Marubini E, Mariani L, Salvadori B, Veronesi U, Saccozzi R, Merson M, Zucali R, Rilke F: Results of a breast cancer surgery trial compared with observational data from routine practice. Lancet 347: 1000–1003, 1996
Borner M, Bacchi M, Goldhirsch A, Greiner R, Hardor F, Castiglione M, Jungi WF, Thürlimann B, Cavalli F, Obrecht JP, Leyvraz S, Alberto P, Adam H, Varini M, Loehnert T, Senn HJ, Metzger U, Brunner K, for the Swiss Group for Clinical Cancer Research: First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation. J Clin Oncol 12: 2071–2077, 1994
Veronesi U, Marubini E, Del Vecchio M, Manzari A, Andreola S, Greco M, Luini A, Merson M, Saccozzi R, Rilke F, Salvadori B: Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst 87: 19–27, 1995
Clark RM, McCullock PB, Levine MN, Lipa M, Wilkinson RH, Mahoney LJ, Basrur VR, Nair BD, McDermot RS, Wong CS, Corbett PJ: Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst 84: 683–689, 1992
Liljegren G, Holmberg L, Adami HO, Westman G, Graffman S, Bergh J, Uppsala-Orebro Breast Cancer Study Group: Sector resection with or without postoperative radiotherapy for stage I breast cancer: five-year results of a randomized trial. J Natl Cancer Inst 86: 717–722, 1994
Early Breast Cancer Trialists' Collaborative Group: Effects of radiotherapy and surgery in early breast cancer — an overview of randomized trials. N Engl J Med 333: 1444–1455, 1995
Schnitt SJ, Hayman J, Gelman R, Eberlein TJ, Love S, Mayzel K, et al.: A prospective study of conservative surgery alone in the treatment of selected patients with stage 1 breast cancer. Cancer 77: 1094–1100, 1996
Morrow M, Harris JR, Schnitt SJ: Local control following breast conserving surgery for invasive cancer: results of clinical trials. J Natl Cancer Inst 87: 1669–1673, 1995
Arriagada R, Kramar A, Le Chevalier T, De Csemoux H for the French Centers' Lung Group: Competing events determining relapse-free survival in limited small-cell lung carcinoma. J Clin Ducol 10: 447–451, 1992
Sullivan Pepe M, Mori M: Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? Stat Med 12: 737–751, 1993
Liu DY: Non-parametric inference for cumulative incidence functions in competing risks studies. Stat Med 16: 901–910, 1997
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schulgen, G., Schmoor, C., Sauerbrei, W. et al. A note on estimating local recurrence rates in clinical trials on the treatment of breast cancer. Breast Cancer Res Treat 49, 87–91 (1998). https://doi.org/10.1023/A:1005969923607
Issue Date:
DOI: https://doi.org/10.1023/A:1005969923607